These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 7453571)

  • 21. Effects of estrogens and progestogens on lipid metabolism.
    Oster P; Arab L; Kohlmeier M; Mordasini R; Schellenberg B; Schlierf G
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):773-5. PubMed ID: 7065057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of exercise, oral contraceptive use, and body fat to concentrations of plasma lipids and lipoprotein cholesterol in young women.
    Merians DR; Haskell WL; Vranizan KM; Phelps J; Woods PD; Superko R
    Am J Med; 1985 Jun; 78(6 Pt 1):913-9. PubMed ID: 3874544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of menopausal status and sequential mestranol and norethisterone on serum cholesterol, triglyceride and electrophoretic lipoprotein patterns.
    Paterson ME; Sturdee DW; Moore B; Whitehead TP
    Br J Obstet Gynaecol; 1979 Oct; 86(10):810-5. PubMed ID: 508663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of kind of carbohydrate in the diet and use of oral contraceptives on metabolism of young women. II. Serum lipid levels.
    Behall KM; Moser PB; Kelsay JL; Prather ES
    Am J Clin Nutr; 1980 Apr; 33(4):825-31. PubMed ID: 7361701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of oral contraceptives and habitual physical activity on serum lipids in black adolescents and young women.
    Linder CW; Durant RH; Jay S; Bryant-Pitts N
    J Adolesc Health Care; 1989 Jul; 10(4):275-82. PubMed ID: 2732106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R; Hilliquin P
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of oral contraceptives on mononuclear cell cholesteryl ester hydrolase activity.
    Hagemenas FC; Yatsu FM; Manaugh LC
    Lipids; 1980 Jan; 15(1):39-44. PubMed ID: 7360009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of triphasic oral contraceptives on plasma lipids and lipoproteins.
    Patsch W; Brown SA; Gotto AM; Young RL
    Am J Obstet Gynecol; 1989 Nov; 161(5):1396-401. PubMed ID: 2686455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
    Nash AL; Cornish EJ; Hain R
    Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of low-dose oral contraceptives on cardiorespiratory function, coagulation, and lipids in exercising young women: a preliminary report.
    Notelovitz M; Zauner C; McKenzie L; Suggs Y; Fields C; Kitchens C
    Am J Obstet Gynecol; 1987 Mar; 156(3):591-8. PubMed ID: 3826206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy.
    Lussier-Cacan S; Xhignesse M; Desmarais JL; Davignon J; Kafrissen ME; Chapdelaine A
    Metabolism; 1991 Aug; 40(8):849-54. PubMed ID: 1907348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholesterol, lipoproteins, and coronary heart disease in women.
    Bush TL; Fried LP; Barrett-Connor E
    Clin Chem; 1988; 34(8B):B60-70. PubMed ID: 3042201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid and lipoprotein changes during the seven days off oral contraception in women using two triphasic preparations.
    Percival-Smith RK; Frohlich J; Jones WN; Abercrombie BA
    Contraception; 1988 Jul; 38(1):19-26. PubMed ID: 3168443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins.
    Arora S; Arora RC; Garg RK; Agarwal N; Nautiyal A
    Indian J Physiol Pharmacol; 1988; 32(1):67-71. PubMed ID: 3169963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in plasma lipid and lipoprotein levels in men and women after a program of moderate exercise.
    Brownell KD; Bachorik PS; Ayerle RS
    Circulation; 1982 Mar; 65(3):477-84. PubMed ID: 7055869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid and lipoprotein changes in women taking low-dose, triphasic oral contraceptives: a controlled, comparative, 12-month clinical trial.
    Notelovitz M; Feldman EB; Gillespy M; Gudat J
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1269-80. PubMed ID: 2655452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.